Novel strain of toxin-producing Strep A identified in the UK
Scientists investigating increased scarlet fever cases have identified that a new dominant linage of Strep A with increased toxin production has emerged.
Browsing: Streptococcus
Group A Streptococcus sequencing reveals potential targets for a global vaccine
A cohort of scientists from the Wellcome Sanger Institute, the University of Cambridge, the Peter Doherty Institute for Infection and Immunity and the University of Queensland have identified novel targets using DNA sequencing, bringing research one step closer to developing a universal vaccine against Group A Streptococcus.
ECCMID18: Could cellulitis be treated with a shorter course of antibiotics?
A new study has investigated whether a 6-day course of antibiotics will give the same outcomes as a 12-day course for treating cellulitis, demonstrating that long-term outcomes may differ.
Can different strains of the same bacterial species elicit varying immune responses?
Researchers have demonstrated that the genetic variation between strains could explain the clinical variation among individuals infected with the same pathogen.
Worldwide burden of group B streptococcal disease estimated for the first time
New research has highlighted the burden of group B streptococcal disease in women and infants worldwide, highlighting the need for a vaccine.
Intercellular peptide identified as a potential therapeutic target in group A Streptococcus
Researchers have discovered that a leaderless intercellular peptide signal may contribute to group A Streptococcus virulence; providing a framework for the identification in other microorganisms that may potentially serve as therapeutic targets.
Oligosaccharides from breast milk could protect against GBS
Researchers have discovered that some oligosaccharides from human breast milk may possess antimicrobial and anti-biofilm properties against Group B Streptococcus (GBS).
Clearing infection from the blood: are endothelial cells unequipped for the job?
New research suggests that blood vessels are unable to clear infection due to the lack of ubiquitination that takes place in the endothelial cells.
Development and delivery of a peptide-based vaccine against group A Streptococcus
In this exclusive piece the authors discuss the choice of peptide antigen, delivery system/adjuvant and delivery route as key factors in the development of an effective human vaccine against group A Streptococcus.
